Eradivir’s EV25 therapeutic reduces advanced-stage influenza viral loads faster, more thoroughly in preclinical studies than current therapies

Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.

New graves tell town’s alarming tale of drug deaths

James Cook Scotland editor BBC James McMillan and Lisa McCuish grew up next to each other and now they lie side by side in Pennyfuir Cemetery James McMillan grew up

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery

Researchers have developed an AI powered model that — in 10 seconds — can determine during surgery if any part of a cancerous brain tumor that could be removed remains,